| Product |
CAS |
Molecular formula |
More |
| 1-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]azetidine |
1569900-22-6 |
C15H22BNO2 |
More |
| 1-(4-Bromophenyl)-4-piperidinemethanamine |
1538984-43-8 |
C12H17BrN2 |
More |
| Piperidin-4-yl morpholine-4-carboxylate |
1519741-86-6 |
C10H18N2O3 |
More |
| Piperidin-4-yl isopropylcarbamate |
1517196-19-8 |
C9H18N2O2 |
More |
| 1-(4-Bromo-3-fluorophenyl)-2,4-imidazolidinedione |
1505136-54-8 |
C9H6BrFN2O2 |
More |
| 1-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-azetidinol |
1430474-51-3 |
C15H22BNO3 |
More |
| 1-(Methylsulfonyl)-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)p |
1428329-80-9 |
C18H28BNO4S |
More |
| B-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]boronic acid |
1417558-60-1 |
C14H21BN2O3 |
More |
| B-[6-[1-[[2-(trimethylsilyl)ethoxy]methyl]-1h-imidazol-2-yl]-3-pyridin |
1417352-20-5 |
C14H22BN3O3Si |
More |
| 1-(4-Bromophenyl)-3-azetidinol |
1416574-02-1 |
C9H10BrNO |
More |
| N-ethyl-5,6-dihydro-pyrrolo[3,4-c]pyrazole-2(4h)-sulfonamide |
1394374-44-7 |
C7H12N4O2S |
More |
| 2-(Cyclopropylmethyl)-2,4,5,6-tetrahydro-pyrrolo[3,4-c]pyrazole |
1394374-41-4 |
C9H13N3 |
More |
| 1-(Cyclopropylmethyl)-1,4,5,6-tetrahydro-pyrrolo[3,4-c]pyrazole |
1394374-39-0 |
C9H13N3 |
More |
| Methyl 5-(1-((2-(trimethylsilyl)ethoxy)methyl)-6-chloro-5-iodo-1h-imid |
1394373-31-9 |
C21H25ClIN3O4Si |
More |
| 6-Chloro-5-iodo-2-(methylsulfonyl)-1-[[2-(trimethylsilyl)ethoxy]methyl |
1394373-30-8 |
C13H19ClIN3O3SSi |
More |
| 6-Chloro-2,3-dihydro-5-iodo-2-(methylthio)-1h-imidazo[4,5-b]pyridine |
1394373-28-4 |
C7H7ClIN3S |
More |
| B-[4-[4-(methylsulfonyl)-1-piperazinyl]phenyl]boronic acid |
1384955-16-1 |
C11H17BN2O4S |
More |
| 5-[[6-Chloro-5-(2-phenylethynyl)-3h-imidazo[4,5-b]pyridin-2-yl]oxy]-2- |
1364699-37-5 |
C22H14ClN3O3 |
More |
| 5-[[6-Chloro-5-[4-(1-hydroxy-1-methylethyl)phenyl]-3h-imidazo[4,5-b]py |
1364697-08-4 |
C23H20ClN3O4 |
More |
| 5-[[6-Chloro-5-(4-cyclopropylphenyl)-3h-imidazo[4,5-b]pyridin-2-yl]oxy |
1364696-91-2 |
C23H18ClN3O3 |
More |
